Blood swap trial aims to boost brain fuel in rare disease
NCT ID NCT04137692
First seen Jan 06, 2026 · Last updated May 18, 2026 · Updated 25 times
Summary
This study is for people with GLUT1 deficiency syndrome, a rare genetic condition that limits glucose (sugar) supply to the brain, often causing seizures and movement problems. The trial will replace the patient's own red blood cells, which lack the glucose transporter, with healthy donor cells to see if this improves brain activity and reduces seizures. The study is currently suspended and aims to enroll 12 participants aged 16 to 80.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.